JAGSONPAL PHARMACEUTICALS (JAGSNPHARM)

NSE: ₹203.45
BSE: ₹202.45
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of 2,96,320 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022.

2026-06-04 16:43:49
Announcement under Regulation 30 (LODR)-Closure of Buy Back

Extinguishment of 16,00,000 Equity Shares of Jagsonpal Pharmaceuticals Limited.

2026-06-02 15:48:01
Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026

2026-05-28 15:10:21
Announcement under Regulation 30 (LODR)-Newspaper Publication

Submission of copy of Post Buy Back Public Advertisement related to Buy back of shares of Company.

2026-05-25 14:53:40
2026-05-18 17:52:02
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company

2026-05-07 15:47:15
Submission Of Letter Of Offer For Buy-Back Upto 16,00,000 Equity Shares

Submission of Letter of Offer for Buy- Back upto 16,00,000 Equity Shares at price of INR-250/- per share amounting to INR-40,00,00,000/-

2026-05-06 20:13:20
Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Earning Call Transcript for meeting held on April 28, 2026

2026-05-04 16:52:42
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement- Extract of Audited Financial Results for FY 26

2026-04-29 18:41:36

Quarterly Financials

Consolidated Standalone
No financial data available for Consolidated.

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Consolidated.